EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 30 / No 6-7 (Juin–Juillet 2014) Med Sci (Paris), 30 6-7 (2014) 624-627 References
Free Access
Issue
Med Sci (Paris)
Volume 30, Number 6-7, Juin–Juillet 2014
Page(s) 624 - 627
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20143006009
Published online 11 July 2014
  1. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995 ; 269 : 546–549. [CrossRef] [PubMed] [Google Scholar]
  2. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999 ; 341 : 879–884. [CrossRef] [PubMed] [Google Scholar]
  3. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995 ; 269 : 540–543. [CrossRef] [PubMed] [Google Scholar]
  4. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996 ; 84 : 491–495. [CrossRef] [PubMed] [Google Scholar]
  5. Coppari R, Ichinose M, Lee CE, et al. The hypothalamic arcuate nucleus: a key site for mediating leptin’s effects on glucose homeostasis and locomotor activity. Cell Metab 2005 ; 1 : 63–72. [CrossRef] [PubMed] [Google Scholar]
  6. Stunkard AJ. Current views on obesity. Am J Med 1996 ; 100 : 230–236. [CrossRef] [PubMed] [Google Scholar]
  7. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995 ; 1 : 1155–1161. [CrossRef] [PubMed] [Google Scholar]
  8. Ogus S, Ke Y, Qiu J, Wang B, Chehab FF. Hyperleptinemia precipitates diet-induced obesity in transgenic mice overexpressing leptin. Endocrinology 2003 ; 144 : 2865–2869. [CrossRef] [PubMed] [Google Scholar]
  9. Myers MG, Jr., Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010 ; 21 : 643–651. [CrossRef] [PubMed] [Google Scholar]
  10. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996 ; 348 : 159–161. [CrossRef] [PubMed] [Google Scholar]
  11. Van Heek M, Compton DS, France CF, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997 ; 99 : 385–390. [CrossRef] [PubMed] [Google Scholar]
  12. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000 ; 105 : 1827–1832. [CrossRef] [PubMed] [Google Scholar]
  13. Langlet F, Levin BE, Luquet S, et al. Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab 2013 ; 17 : 607–617. [CrossRef] [PubMed] [Google Scholar]
  14. Balland E, Dam J, Langlet F, et al. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab 2014 ; 19 : 293–301. [CrossRef] [PubMed] [Google Scholar]
  15. Vatier C, Capeau J, Vigouroux C. La leptine, nouvelle perspective thérapeutique dans le traitement du diabète ?. Med Sci (Paris) 2010 ; 26 : 803–807. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.